| GHAIX | PGNAX | GHAIX / PGNAX | |
| Total Expense Ratio | 0.96 | 1.26 | 76% |
| Annual Report Gross Expense Ratio | 1.11 | 1.26 | 88% |
| Fund Existence | 20 years | 37 years | - |
| Gain YTD | 25.932 | 27.407 | 95% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 1000000 | 1000 | 100,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 654M | 1.01B | 65% |
| Annual Yield % from dividends | 1.65 | 0.84 | 196% |
| Returns for 1 year | 46.50 | 56.80 | 82% |
| Returns for 3 years | 67.76 | 73.73 | 92% |
| Returns for 5 years | 98.83 | 144.71 | 68% |
| Returns for 10 years | 102.22 | 172.76 | 59% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RYEUX | 138.69 | 1.39 | +1.01% |
| Rydex Europe 1.25x Strategy H | |||
| LVAVX | 17.34 | 0.12 | +0.70% |
| LSV Conservative Value Equity Investor | |||
| WHGOX | 13.52 | 0.03 | +0.22% |
| Westwood Income Opportunity Ultra | |||
| JFNAX | 89.91 | N/A | N/A |
| Janus Henderson Global Life Sciences A | |||
| FIQJX | 23.22 | N/A | N/A |
| Fidelity Advisor Intl Sm Cap Opps Z | |||